Analysis of Hematological and Biochemical Parameters in Patients with Rheumatoid Arthritis in Sulaymaniyah

Khafar, Kaniaw; Karim, Meer; Qadr, Nma; Noori, Saya; Mohammed, Savia; Salah, Shady

doi:10.33899/mjn.2024.182200

	Analysis of Hematological and Biochemical Parameters in Patients with Rheumatoid Arthritis in Sulaymaniyah
Mosul Journal of Nursing
Article 15, Volume 12, Issue 1, January 2024, Pages 144-152 PDF (332.33 K)
Document Type: Original Articles
DOI: 10.33899/mjn.2024.182200
Authors
Kaniaw Khafar¹; Meer Karim²; Nma Qadr²; Saya Noori²; Savia Mohammed²; Shady Salah²
¹Department of Nursing, Halabja Technical Institute, Sulaimani Polytechnic University, Sulaimani City, Iraq.
²Department of Medical Laboratory, College of Health and Medical Technology, Sulaimani Polytechnic University, Sulaimani City, Iraq
Abstract
Background: Rheumatoid arthritis (RA) is a chronic immune-mediated systemic inflammatory disease characterized by chronic synovial inflammation and hyperplasia, which drive joint erosion and damage, and a variety of systemic manifestations, which contribute to the overall burden of the disease, certain environmental and/or genetic risk factors can lead to the awakening of systemic autoimmunity. For this reason, this current research is designed to investigate some haematological and biochemical parameters in patients with rheumatoid disease in the Kurdistan region. Methods The investigation included healthy groups of 50 healthy people (21 men and 29 women) and 162 patients with rheumatoid disease (43 men and 119 women). The disease was diagnosed at Shahid Dr Hemn Hospital and Smart Health Tower from October 2022 to December 2022. SPSS statistical software (Version 20) (social science statistical package) was used to analyze the data. Differences in mean values between 2 groups were analyzed by two samples' t-tests (independent student's t-test). Results The results highlighted that rheumatoid disease was significantly correlated with age, sex, and daily exercise. Haematological markers (WBC, HGB) changed significantly, and inflammatory markers (ESR, CRP) also increased significantly in the rheumatoid disease groups in both genders. Conclusion: This study found that rheumatoid disease induces alterations in a majority of physiological and haematological markers within the body. Elevated levels of inflammation markers, particularly in individuals with rheumatoid disease, were associated with noticeable manifestations such as joint swelling, stiffness, or redness.
Keywords
Rheumatoid Arthritis Patients; Demographic Factors; Hematologic Markers; Inflammation Markers
Supplementary Files 144_152.xml
References
"Prevalence of metabolic syndrome in Iraqi patients with rheumatoid arthritis." IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 1(11): 69-72. https://doi.org/10.9790/0853-1116972 Alamanos, Y. and A. A. Drosos (2005). "Epidemiology of adult rheumatoid arthritis." Autoimmunity Reviews 4(3): 130-36.https://doi.org/10.1016/j.autrev.2004.09.002 Amital, H., Y. Arnson, G. Chodick, and V. Shalev (2009). "Hepatotoxicity rates do not differ in patients with methotrexate-treated rheumatoid arthritis and psoriasis treated with methotrexate." Rheumatology 48(9): 1107-1110. https://doi.org/10.1093/rheumatology/kep176 Badsha, H. (2018). 'The role of diet in the influence of the activity of rheumatoid arthritis disease." The open rheumatology journal 12: 19. https://doi.org/10.2174/1874312901812010019 Boots, M.M., B. Maier, P. Stinissen, P. Masson, RJ Lories and F. De Keyser (2013). "The influence of ageing on the development and treatment of rheumatoid arthritis." Nature Reviews Rheumatology 9(10): 604-613. https://doi.org/10.1038/nrrheum.2013.92 Deane, K. D., M. K. Demoruelle, L. B. Kelmenson, K. A. Kuhn, J. M. Norris, and V. M. Holers (2017). "Genetic and environmental risk factors for rheumatoid arthritis." Best Practice & Research Clinical Rheumatology 31(1): 3-18. https://doi.org/10.1016/j.berh.2017.08.003 Isaacs, JD, A. Zuckerman, S. Krishnaswami, C. Nduaka, S. Lan, M. M. Hutmacher, M. G. Boy, K. Kowalski, S. Menon, and R. Riese (2014). "Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results of clinical trials." Arthritis Research & Therapy 16: 1-12. https://doi.org/10.1186/ar4673 Ishida, M., Y. Kuroiwa, E. Yoshida, M. Sato, D. Krupa, N. Henry, K. Ikeda, and Y. Kaneko (2018). "Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review." Modern Rheumatology 28(5): 789-799. https://doi.org/10.1080/14397595.2017.1416940 Källberg, H., B. Ding, L. Padyukov, C. Bengtsson, J. Rönnelid, L. Klareskog, L. Alfredsson and E. S. Group (2011). "Smoking is a major preventable risk factor for rheumatoid arthritis: estimates of risks after various exposures to cigarette smoke." Annals of the Rheumatic Diseases 70(3): 508-511. https://doi.org/10.1136/ard.2009.120899 Lyngdoh, T., P. Marques-Vidal, F. Paccaud, M. Preisig, G. Waeber, M. Bochud and P. Vollenweider (2011). "Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study." PloS One 6(5): e19901. https://doi.org/10.1371/journal.pone.0019901 Masson, C. (2011). "Rheumatoid anemia." Joint Bone Spine 78(2): 131-137. https://doi.org/10.1016/j.jbspin.2010.05.017 Michaud, K., J. Pope, M. van de Laar, J. R. Curtis, C. Kannowski, S. Mitchell, J. Bell, J. Workman, J. Paik and A. Cardoso (2021). 'Systematic review of residual symptoms and an unmet need in patients with rheumatoid arthritis." Arthritis care & research 73(11): 1606-1616. https://doi.org/10.1002/acr.24369 Mititelu, R. R., R. Pădureanu, M. Băcănoiu, V. Pădureanu, A. O. Docea, D. Calina, A. L. Barbulescu and A. M. Buga (2020). "Inflammatory and oxidative stress markers-mirror tools in rheumatoid arthritis." Biomedicines 8(5): 125. https://doi.org/10.3390/biomedicines8050125 Nilsson, J., M. L. Andersson, I. Hafström, B. Svensson, K. Forslind, S. Ajeganova, M. Leu Agelii and I. Gjertsson (2021). "Influence of age and sex on the course and treatment of rheumatoid arthritis." Open access rheumatology: research and reviews: 123-138. https://doi.org/10.2147/OARRR.S306378 Olago-Rakuomi, A.A. (2017). Prevalence of abnormal liver function tests in rheumatoid arthritis, University of Nairobi. Prasad, P., S. Verma, Surbhi, N. K. Ganguly, V. Chaturvedi, and S. A. Mittal (2023). "Rheumatoid arthritis: advances in treatment strategies." Molecular and Cellular Biochemistry 478(1): 69-88. https://doi.org/10.1007/s11010-022-04492-3 Selmi, C., M. De Santis, and M. E. Gershwin (2011). "Liver involvement in subjects with rheumatic disease." Arthritis research & therapy 13: 1-6. https://doi.org/10.1186/ar3319 Smith, M. H. and J. R. Berman (2022). "What is rheumatoid arthritis?" JAMA 327(12): 1194-1194. https://doi.org/10.1001/jama.2022.0786 Sokka, T. and A. Hakkinen (2008). "Poor physical fitness and performance as predictors of mortality in normal populations and patients with rheumatic and other diseases." Clinical & Experimental Rheumatology 26(5): S14. Tekeolu,., G. Gürol, H. Harman, E. Karakeçe, and İ. H. iftçi (2016). "Overlooked hematological markers of disease activity in rheumatoid arthritis." International Journal of Rheumatic Diseases 19(11): 1078-1082. https://doi.org/10.1111/1756-185X.12805 Weyand, C. M. and J. J. Goronzy (2021). "The immunology of rheumatoid arthritis." 22(1): 10-18.
Statistics Article View: 804 PDF Download: 296